The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
<iframe src="https://statesidedaily.com/embed/cluster/2e67158068c5ac6f367d6d6f9938c6250af3dd4e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Enveda secures $311M to bring more nature-derived AI drugs into clinical trials"></iframe>
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
